Skip to content

Clinical trials

Multiple Sclerosis, Relapsing-Remitting trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Country / region: Israel Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20051
20062
20074
20081
20093
20102
20111
20121
20132
20142
20151
20181
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated4
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen10
Bayer4
Genzyme, a Sanofi Company3
Mapi Pharma Ltd.2
Eli Lilly and Company1
Grifols Therapeutics LLC1
Novartis1
Novartis Pharmaceuticals1
RedHill Biopharma Limited1
Sheba Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting27
Multiple Sclerosis14
Recurrence4
Multiple Sclerosis, Chronic Progressive1
Sclerosis1

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.